Page 11 - Pfizer

'Pfizer jab side effects in 12-15 year olds at high risk, mild to moderate'

A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate

US plans Covid-19 booster shots at six months instead of eight: Report

Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older

Heart inflammation more common after Covid than Pfizer vaccine: Study

Pfizer's Covid vaccine has been linked with an increased risk of developing myocarditis -- a type of heart inflammation.

Pfizer seeking FDA approval for coronavirus vaccine booster dose

Pfizer is seeking US approval of a booster dose of its two-shot COVID-19 vaccine. The drugmaker said Wednesday that it has started the application process for a third dose of its vaccine for people ages 16 and older. The company said it will complete the application with the Food and Drug Administration by the end of this week. The company's move follows an announcement by U.S. health officials last week of plans to give COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant of the virus. Officials said it is very clear that the vaccines' protection against COVID-19 infections wanes over time. Pfizer's vaccine received full FDA approval earlier this week; it had been used since last December under an emergency use authorization. The three vaccines used in the U.S. made by Pfizer, Moderna and Johnson & Johnson are still preventing hospitalizations and deaths from COVID-19. But the vaccines don't appear quite as strong against the highly .

Explained: What FDA full approval to Pfizer-BioNTech vaccine means

The research to develop a safe and effective Covid-19 vaccine was accelerated in 2020

Fauci expects uptick in vaccine administration after FDA OKs Pfizer shot

Dr. Anthony Fauci says he's hoping for an uptick in the administration of Covid-19 vaccinations following US government approval of the Pfizer vaccine

US FDA grants full approval to Pfizer-BioNTech Covid vaccine

The FDA approved the two-dose vaccine for use in people over the age of 16.

Pfizer to acquire cancer drugmaker Trillium Therapeutics for $2.3 bn

Pfizer will pay $18.50 a share for Cambridge, Massachusetts-based Trillium, the companies said Monday in a statement.

Pfizer and Astra vaccines less effective after 90 days, says study

The Oxford University study found that 90 days after a second shot of the Pfizer or Astra vaccine, their efficacy in preventing infections had slipped to 75 per cent and 61 per cent, respectively

Pfizer, AstraZeneca vaccines less effective against Delta variant: Study

The COVID vaccines by Pfizer and AstraZeneca are less effective against the Delta variant compared to the Alpha variant, according to a study led by researchers at the University of Oxford

Covid vaccines fight off infections but less effective against delta: Study

Results from UK survey are likely to fuel calls to give booster shots to the fully vaccinated.

Covid-19 pandemic: US okays third jab for those with low immunity

The amended emergency use authorization paves the way for people who have had an organ transplant, or those with a similar level of weakened immune system, to get an extra dose

Moderna Covid vaccine 76% effective against Delta, Pfizer 42%: Study

Covid-19 jabs that were developed by US drug makers Pfizer and Moderna may not be as effective against the 'Delta' variant compared to as they were against the original strain of the virus, says study

RDIF proposes Pfizer conduct joint trial with Sputnik Light as booster shot

The Russian Direct Investment Fund (RDIF) has proposed that US drugmaker Pfizer start joint trials with Sputnik Light as a booster COVID-19 vaccine shot, the RDIF said on Wednesday."Delta cases surge in US & Israel shows mRNA vaccines need a heterogeneous booster to strengthen & prolong immune response. #SputnikV pioneered mix & match approach, combo trials & showed 83.1% efficacy vs Delta. Today RDIF offers Pfizer to start trial with Sputnik Light as booster," it said in a Tweet.It further said that Sputnik V is the first in the world to offer combo trial to AstraZeneca in November 2020, co-sponsored mix & match trials with AstraZeneca, Moderna and Sinopharm."Sputnik V was the 1st in the world to offer combo trial to AstraZeneca in Nov 2020, co-sponsored mix & match trials with AstraZeneca, Moderna & Sinopharm. Since then heterogeneous boosting pioneered by Sputnik proved to be effective vs mutations," it added further.According to an official ...

Pfizer shares hit record high with Covid-19 vaccine stocks on a tear

The percentage gain was the stock's biggest one-day rise since Nov. 9, when Pfizer released positive data for its Covid-19 vaccine

BioNTech says has supplied more than 1 billion Covid vaccine doses so far

BioNTech and partner Pfizer have supplied more than one billion doses of their vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca the German biotech Group said

J&J seeks approval for single-dose Covid-19 vaccine in India

It is not clear whether J&J is seeking indemnity against adverse events following vaccination like its US peers

Pfizer, Moderna raise prices for Covid-19 vaccines in European Union

The terms of the deals were renegotiated after Phase 3 clinical trial data showed vaccines from the two companies are more effective than some rivals

India may soon have Covid-19 vaccines for children. All you need to know

Zydus Cadila DNA-plasmid vaccine is the prime contender. It has held trials on children aged 12 years and above

World Coronavirus Dispatch: Israel offers Pfizer booster jab to the 60-plus

China says it has made alternative proposal for virus origin probe, EU pulls ahead of US in vaccinations, and other pandemic-related news across the globe